George Clinical
The Sydney, Australia-headquartered CRO has appointed James Cheong to chief operating officer (COO). Based at the company’s Singapore office, Cheong will lead global operations and direct the company's administrative functions.
Cheong said, “Over many years, I have watched with interest how George Clinical has grown both as a leading full-service CRO in the Asia Pacific and as a strong advocate of pragmatic trial solutions, executing clinical trials to the highest quality standards and operational excellence, with scientific expertise as an invaluable differentiator.”
Cheong told us he is excited about taking the next step in his career, with a company he believes shows incredible promise, and “the winning formula of being big enough globally to meet all our customers’ needs, yet our agility and service focus are able to help our start-up/biotech customers not feel lost in the clinical trial process.”
“George Clinical is a company that has clearly developed an enviable footprint in the Asia-Pacific and North America, across a variety of therapy areas, particularly in the areas of oncology, renal, vascular and respiratory,” he said.
Cheong was previously the head of clinical operations for the Chinese market at Boehringer Ingelheim.
Prior to Boehringer Ingelheim, he was the vice president of clinical development at EPS International in the Asia Pacific, and has held various leadership roles at global CROs.